Clinical Trial Update: Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing cabazitaxel in patients with recurrent ovarian cancer after failure of standard therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Vejle Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED